Real-time enrollment status for this geographic atrophy clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 2:10 PM UTC
| NCT Number | NCT07594236 |
| Recruiting Status | Recruiting |
| Condition | Geographic Atrophy |
| Phase | PHASE1 |
| Target Enrollment | 15 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Cellio Therapeutics Inc |
| Last Updated on CT.gov | August 17, 2026 (1 week ago) |
As of August 29, 2026: Clinical trial NCT07594236 is currently recruiting participants. This phase1 study for geographic atrophy is actively seeking new participants at 3 locations across the United States. The study is sponsored by Cellio Therapeutics Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07594236 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07594236 was last updated 1 week ago (August 17, 2026). HelloStudys verifies this status automatically.